AngioDynamics (ANGO) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Paradium AI (PAAI) Halted, News Pending
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
July 16, 2015 4:01 PM EDTFourth quarter fiscal 2015 net sales of $90.9 million; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash generation of $10.8 million; Full year operating cash generation of $26.2 million Preliminary FY2016 guidance of 2% - 4% sales growth and 7% - 14% adjusted EPS growth
ALBANY, N.Y., July 16, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider... More
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
July 16, 2015 4:01 PM EDTFourth quarter fiscal 2015 net sales of $90.9 million; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash generation of $10.8 million; Full year operating cash generation of $26.2 million Preliminary FY2016 guidance of 2% - 4% sales growth and 7% - 14% adjusted EPS growth
ALBANY, N.Y., July 16, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider... More
